Webinar: Capsid titre quantification for AAV-based therapeutics
Cell and gene therapies require development of fit for purpose analytical tools to support bioprocess development, for biopharmaceutical characterization and lot release testing.
Cell and gene therapies require development of fit for purpose analytical tools to support bioprocess development, for biopharmaceutical characterization and lot release testing.
Measuring Anti-Drug-Antibody (ADA) levels is an important part of developing new biologics. The clinical implication of the presence of anti-drug-antibodies in treated patients may include allergic reactions, immune complex toxicity, autoimmune reactions and reduction of efficacy.
Products are for professional/laboratory use only. Gyros has developed a three-step bridging Gyrolab assay with a broad assay range (40 to 200,000ng/mL) for qualitative detection of total antibodies generated against the spike protein (RBD) of SARS-CoV-2 in human serum samples.
Impurity testing of biotherapeutics? Try the new Gyrolab CHO-HCP E3G Kit. Now available in a ready to use kit optimized for Gyrolab® Systems.